In summary, modern PROTAC technologies, including antibody–PROTAC, aptamer-PROTAC, dual-target PROTAC, folate-caged PROTAC, and TF–PROTAC, represent significant advancements in precise and effective cancer treatment. This evidence concerns the gene TF and cancer.